If a drug test does include semaglutide, it is usually for medical purposes or specialized testing in sports and certain professions
January 2026 milestone: The FDA approved an oral formulation of Wegovy (semaglutide) for chronic weight management in December 2025 the first GLP-1 pill ever approved for obesity treatment
If you are five weeks into a GLP-1 and wondering whether feeling this queasy is normal, and how much longer it goes on: it is normal, it is the single most common effect of these medicines, and of all the gastrointestinal side effects it is the one that passes fastest
For a safe, personalized experience, trust us with your health
Side effects linked to collagen loss and facial morphology changes: Skin laxity Write-off of subcutaneous fat results in droop and folds, particularly in cheeks, jowls, and neck